Healthtech startup CURAPOD raises Rs 20 Cr in pre-Series A round

Healthtech startup CURAPOD has raised Rs 20 crore (around $2.2 million) in a pre-Series A round led by V3 Ventures, 3i Partners, and Ideaspring Capital. CURAPOD is backed by Litemed.

The fresh capital will be used to accelerate research and development, enhance its device and companion app, scale manufacturing, and expand go-to-market efforts. 

It also plans to strengthen its direct-to-consumer presence, expand partnerships with gyms, physiotherapy centres, and sports medicine networks, and improve operational efficiencies.

Founded in 2022 by Sri Velliyur and Surya Maguluri, CURAPOD develops wearable, non-invasive pain management devices focused on musculoskeletal conditions. 

The brand’s device uses photobiomodulation therapy and is designed to address conditions such as back pain, neck pain, knee pain, joint disorders, muscle stiffness, and sports-related injuries.

The device is FDA-registered and supports more than 30 musculoskeletal conditions, offering a drug-free alternative to conventional pain management methods. The firm follows a clinician-led adoption model and is expanding its footprint across India.